Centinel Spine® Announces First International Use of 3D-Printed Porous Titanium FLX™ Platform

Centinel Spine®, LLC, a leading global medical device company addressing cervical and lumbar spinal disease through anterior surgical access, today announced the first international implantation of the 3D-Printed Porous Titanium FLX™ platform. Dr. Alfredo Guiroy and Dr. Jose Ricardo Prina in Argentina were the first surgeons outside the United States to implant the STALIF C FLX™ and STALIF M FLX™ devices.

The FLX platform represents the latest material evolution offered by Centinel Spine. The STALIF C FLX and STALIF M FLX devices are 3D-printed porous titanium Integrated Interbody™ implants that have been engineered to mimic bone. These implants provide equivalent subsidence performance to PEEK; contain a proprietary, interconnected FUSE-THRU™ lattice with a structure and modulus of elasticity similar to bone; and have optimized mechanical, visual, and osteophilic environments that reduce stress shielding, enable fusion assessment, and support bony in-growth, on-growth, and thru-growth.

“The STALIF M FLX cage has a bone contact surface much better and larger than any other PEEK cage of the same size and has a maximum capability of osteointegration with the bone,” said Dr. Prina. “We consider that this works much better for a stand-alone procedure.”

“It is my pleasure to use STALIF®. It’s a very good implant, with a lot of versatility due to different sizes and lordotic options, and titanium has shown to be more friendly for fusion than other PEEK/hybrid combinations,” commented Dr. Guiroy.

Centinel Spine’s CEO, Steve Murray, stated, “We are excited to be able to offer our state-of-the-art FLX technology to our international partners. As a company, we remain dedicated to continued innovation and furthering scientific evidence in advancing spine care. We are proud to be able to make our technology available to even more patients on a global scale.”

STALIF M FLX and STALIF C FLX implants are built upon the proven STALIF design, which has over 30 years of clinical history and has helped many patients regain their lives. STALIF implants provide compressive fixation at the fusion site, pulling the vertebral bodies onto the implant and graft material to enhance opportunities for fusion in line with Wolff’s Law of Bone Healing.

Hot this week

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.